Research update: Mild cognitive impairment (MCI) - Definition, diagnosis, and treatment possibilities

Advanced Studies in Medicine

Volumn 4, Issue 6, 2004, Pages 290-296

  Rabins, Peter V ^a,b,c  

^a Geriatric Psychiatry Clinic   (United States)

^b Geriat and Neuropsychiatry Section   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; AMPA RECEPTOR ANTAGONIST; AMPAKINE; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; GESTAGEN; PIRIBEDIL; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; DEMENTIA; DRUG EFFECT; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; MEDICAL RESEARCH; MEDICAL SOCIETY; MEMORY DISORDER; MILD COGNITIVE DEFECT; PATIENT MONITORING; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; REVIEW; SCREENING;

EID: 2942630758     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Alzheimer's Disease Education and Referral Center Web site. General Information page. Available at: www.alzheimers. org/generalinfo.htm#howmany. Accessed May 19, 2003.
2. Shah Y, Tangalos EG, Petersen RC. Mild cognitive impairment: when is it a precursor to Alzheimer's disease? Geriatrics. 2000;55:62,65-68.
3. American Medical Association Web site. Excerpts from the AMA Dementia Guide to Diagnosis, Management, and Treatment of Dementia. Available at: www.ama-assn.org/ama/ pub/category/4789.html. Accessed March 2, 2004.
4. Kral VA. Senescent forgetfulness: benign and malignant, Can Med Assoc J. 1962;86:257-260.
5. Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr. 1994;6:63-68. Erratum in: Int Psychogeriatr. 1994;6:133.
6. Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr. 1994;6:63-68. Erratum in: Int Psychogeriatr. 1994;6:133.
7. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Age associated memory impairment: proposed diagnostic criteria and measures of clinical change: report of a National Institute of Mental Health Work Group. Dev Neuropsychol. 1986;2:261-276.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000:740.
9. Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet. 1997;349:1793-1796.
10. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985-1992.
11. Burns A, Zaudig M. Mild cognitive impairment in older people. Lancet. 2002;360:1963-1965.
12. Barker A, Jones R, Jennison C. A prevalence study of age-associated memory impairment. Br J Psychiatr 1995;167:642-648.
13. Coria F, Gomez de Caso JA, Minguez F, Rodriguez-Artalejo F, Claveria LE. Prevalence of age-associated memory impairment and dementia in a rural community. J Neurol Neurosurg Psychiatr. 1993;56:973-976.
14. Larrabee GJ, Crook TH 3rd. Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function. In Psychogeriatr. 1994;6:95-104.
15. Smith G, Ivnik RJ, Petersen RC, Malec FJ, Kokmen E, Tangalos E. Age-associated memory impairment diagnoses: problems of reliability and concerns for terminology. Psychol Aging. 1991;6:551-558.
16. Tabert MH, Albert SM, Borukhova-Milov BA, et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology. 2002;58:758-764.
17. Tuokko H, Frerichs R, Graham J, et al. Five-year follow-up of cognitive impairment with no dementia. Arch Neurol. 2003;60:577-582.
18. Tierney MC, Szalai JP, Snow WG, et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology. 1996;46:661-665.
19. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995;273:1274-1278. Erratum in: JAMA. 1995;274:538.
20. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995;273:1274-1278. Erratum in: JAMA. 1995;274:538.
21. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB. Progression to dementia in patients with isolated memory loss. Lancet. 1997;349:763-765.
22. Nagaraja D, Jayashree S. Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment. Am J Psychiatry. 2001;158:1517-1519.
23. Johnson SA, Simmon VF. Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report. J Mol Neurosci. 2002;19:197-200.
24. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289:2651-2662.
25. Rapp SR, Espeland MA, Shumaker SA, et al. Effect of estrogen plus progestin on global cognitive function in post-menopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003; 289:2663-2672.
26. Ball K, Berch DB, Helmers KF, et al. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA. 2002;288:2271-2281.
27. US Preventive Services Task Force. Screening for dementia: recommendation and rationale. Ann Intern Med. 2003; 138:925-926.
28. Canadian Guide to Clinical Prevention Health Care. Canadian Task Force on the Periodic Health Examination. Ottawa, Canada: Canada Communication Group; 1994:902-909.
29. Santacruz KS, Swagerly D. Early diagnosis of dementia. Am Fam Physician. 2001;63:703-713,717-718.
30. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1133-1142.
31. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269:2386-2391.
32. Palmer K, Backman L, Winbiad B, Fratiglioni L. Detection of Alzheimer's disease and dementia in the preclinical phase: population-based cohort study. BMJ. 2003;326:245.
33. Teri L, Gibbons LE, McCurry SM, et al. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA. 2003;290:2015-2022.
34. Wang L, van Belle G, Kukull WB, Larson EB. Predictors of functional change: a longitudinal study of nondemented people aged 65 and older. J Am Geriatr Soc. 2002;50:1525-1534.
35. Ball LJ, Birge SJ. Prevention of brain aging and dementia. Clin Geriatr Med. 2002;18:485-503.
36. Black BS, Kasper J, Brandt J, et al. Identifying dementia in high-risk community samples: the memory and medical care study. Alzheimer Dis Assoc Disord. 2003;17:9-18.